Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Yu Xia, Min Guo, Tiantian Xu, Yinghua Li, Changbing Wang, Zhengfang Lin, Mingqi Zhao & Bing Zhu. (2018) siRNA-loaded selenium nanoparticle modified with hyaluronic acid for enhanced hepatocellular carcinoma therapy. International Journal of Nanomedicine 13, pages 1539-1552.
Read now
Read now
Articles from other publishers (6)
Filipe M. O. Silva, Priscila O. Carvalho, Elerson C. Costalonga, Rafael Pepineli, Raul C. Maranhão & Irene L. Noronha. (2022) Use of paclitaxel carried in solid lipid nanoparticles to prevent peritoneal fibrosis in rats. PLOS ONE 17:5, pages e0268197.
Crossref
Crossref
Michael K. Danquah & Jaison Jeevanandam. 2022. Emerging Nanomedicines for Diabetes Mellitus Theranostics. Emerging Nanomedicines for Diabetes Mellitus Theranostics
199
224
.
Siddharth Adityan, Michelle Tran, Chintan Bhavsar & Sherry Y. Wu. (2020) Nano-therapeutics for modulating the tumour microenvironment: Design, development, and clinical translation. Journal of Controlled Release 327, pages 512-532.
Crossref
Crossref
Jenni Firrman, LinShu Liu, Ceylan Tanes, Kyle Bittinger, Karley Mahalak & William Rinaldi. (2019)
Metagenomic assessment of the
Cebus apella
gut microbiota
. American Journal of Primatology 81:10-11.
Crossref
Crossref
Fernando L. T. Gomes, Raul C. Maranhão, Elaine R. Tavares, Priscila O. Carvalho, Maria L. Higuchi, Fernando R. Mattos, Fabio G. Pitta, Sergio A. Hatab, Roberto Kalil-Filho & Carlos V. SerranoJrJr. (2018) Regression of Atherosclerotic Plaques of Cholesterol-Fed Rabbits by Combined Chemotherapy With Paclitaxel and Methotrexate Carried in Lipid Core Nanoparticles. Journal of Cardiovascular Pharmacology and Therapeutics 23:6, pages 561-569.
Crossref
Crossref
Silvia R. Graziani, Carolina G. Vital, Aleksandra T. Morikawa, Brigitte M. Van Eyll, Hezio J. Fernandes Junior, Roberto Kalil Filho & Raul C. Maranhão. (2017) Phase II study of paclitaxel associated with lipid core nanoparticles (LDE) as third-line treatment of patients with epithelial ovarian carcinoma. Medical Oncology 34:9.
Crossref
Crossref